Adults who microdose psychedelics report health related motivations and lower levels of anxiety and depression compared to non‑microdosers
Key Points
Microdosers report significantly lower levels of anxiety and depression than non-microdosers, highlighting potential therapeutic effects.
The analysis involves self-reported health-related motivations for microdosing, indicating that mental wellness is a priority for participants.
Assessment of psychological outcomes reveals a notable correlation between microdosing and improved mental health metrics over time.
Potential mental health benefits may indicate the therapeutic use of psychedelics, emphasizing the need for further investigation on long-term effects.